UTI Large and Mid Cap Fund · Regular · Growth
NAV
₹188.9758
as of 03 Aug 2026
Expense Ratio
1.83%
AUM
₹5,912 Cr
Lumpsum returns (CAGR)
- 1Y
- +7.79%
- 3Y
- +16.84%
- 5Y
- +14.76%
- Since Inception
- +11.46%
SIP returns (XIRR)
- 1Y
- +9.19%
- 3Y
- +10.54%
- 5Y
- +15.21%
- Since Inception
- +12.07%
Returns calculated from 21 June 2019 onwards due to a structural change in the scheme on that date. Earlier NAV history is preserved but excluded from multi-year return calculations. Periods spanning this date show —.
What history actually did — last 10 years (Aug 2016 – Jul 2026)
A ₹5,000 monthly SIP for the last 10 years (Aug 2016 – Jul 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹13,39,027 today — ₹5,95,000 invested, 15.7% XIRR.
₹5,95,000
Invested
₹13,39,027
Value today
15.7%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 10 years (Aug 2016 – Jul 2026)
Real NAV backtest
₹1,00,000 invested 10 years ago would be ₹3,63,940 today (13.8% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Aug 2016 would still hold ₹23,00,374.
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹13,39,027 in this fund vs ₹13,49,755 in the benchmark — underperformance of ₹10,728.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 10 years (Aug 2016 – Jul 2026) (22 Mar 2020) would be ₹4,72,942 today (4.73×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised0.18
Sharpe Ratio
+0.03
Alpha
0.36
Beta
0.17
Sortino
14.00%
Std Dev
-13.56%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 31 May 2026- Banks15.94%
- Pharmaceuticals & Biotechnology8.72%
- IT - Software7.72%
- Finance7.20%
- Insurance5.24%
- Telecom - Services4.29%
- Automobiles4.26%
- Construction3.97%
- Power3.56%
- Realty3.33%
- Transport Services3.04%
- Diversified FMCG2.65%
Each sector links to the mutual funds most exposed to it.
Thinking about UTI Large and Mid Cap Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Available transactions
Portfolio holdings
- 1Hdfc Bank Limited5.49%
- 2Icici Bank Ltd3.57%
- 3Larsen & Toubro Ltd.2.90%
- 4Itc Ltd.2.65%
- 5State Bank Of India2.65%
- 6Bharti Airtel Ltd.2.65%
- 7Aurobindo Pharma Ltd.2.49%
- 8Infosys Ltd.2.47%
- 9Aditya Birla Capital Ltd2.45%
- 10Power Grid Corporation Of Indi2.42%
Investment Objective
UTI Large and Mid Cap Fund · Regular · Growth seeks to generate long-term capital appreciation by investing in mid-cap companies — ranked 101st to 250th by market capitalisation. These companies offer a balance of growth potential and relative stability, making them suitable for investors with moderate to high risk appetite.
About This Fund
UTI Large and Mid Cap Fund · Regular · Growth is a Large & Mid Cap mutual fund offered by UTI Mutual Fund. The fund has been operational for over 33 years. It manages assets worth ₹5,912 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against Nifty LargeMidcap 250 TRI. The current expense ratio is 1.83%.
Who Should Invest?
- •Aggressive investors comfortable with significant short-term volatility
- •Investors with a long-term horizon of 7+ years who can ride out market cycles
- •SIP investors who can benefit from rupee cost averaging during market fluctuations